# 2015/10/12 HSA Fluorescent Competition Assay

Performed by Mehtap Isik.  
For lab notebook: https://drive.google.com/drive/u/0/folders/0BykO-ZGQb9DHMzBIRWE5NUFQbFU

- Protein: Human Serum Albumin (HSA)  
- Fluorescent probe ligand: Dansylamide
- Non-fluorescent ligand: Phenylbutazone or Indomethacin

## Protein and Buffer Solutions
HSA stock solution concentration in this assay is 0.5 uM. It is prepared by dilution of 10.0 uM HSA solution (prepared on 2015/09/10).  
Buffer: 100 mM sodium phosphate buffer, pH 7.4 (i.e. CB7 Host-Guest Buffer)

## Plate Layout
Row A : HSA    + Dansylamide titration  
Row B : buffer + Dansylamide titration  
Row C : HSA    + Dansylamide titration + constant concentration of phenylbutazone (10 uM)  
Row D : HSA    + Dansylamide titration + constant concentration of phenylbutazone (10 uM)  
Row E : buffer + Dansylamide titration + constant concentration of phenylbutazone (50 uM)  
Row F : buffer + Dansylamide titration + constant concentration of phenylbutazone (50 uM)  
Row G : HSA    + Dansylamide titration + constant concentration of indomethacin (10 uM)  
Row H : buffer + Dansylamide titration + constant concentration of indomethacin (50 uM)  

- Plate type: 4ti_0223 (96 well, black clear bottom)  

## Files
Infinite data file:  
`MI_FLU_hsa_lig1_20151117_110602.xml`

D300 simulation report:  
`MI_FLU_hsa_lig1_pb_20151113 2015-11-13 1350.DATA.xml` - D300 simulation report for dispensing Dansyl amide, Phenylbutazone or Indomethacin.

Compound stocks spreadsheet:  
`ligand_DMSO_stocks.csv` - DAM001, PHE001 and IND001 DMSO stocks are used in this experiment.

